Baicalein inhibits progression of gallbladder cancer cells by downregulating ZFX

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Liu, Tian Yu ^a,b   Gong, Wei ^a,b   Tan, Zhu Jun ^a,b   Lu, Wei ^a,b   Wu, Xiang Song ^b   Weng, Hao ^b   Ding, Qian ^b   Shu, Yi Jun ^b   Bao, Run Fa ^b   Cao, Yang ^b   Wang, Xu An ^b   Zhang, Fei ^b   Li, Huai Feng ^b   Xiang, Shan Shan ^b   Jiang, Lin ^a,b   Hu, Yun Ping ^a,b   Mu, Jia Sheng ^b   Li, Mao Lan ^b   Wu, Wen Guang ^b   Shen, Bai Yong ^b   Jiang, Li Xin ^c   Liu, Ying Bin ^a,b   more..

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c Jiangyin Hospital of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BAICALEIN; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN X LINKED; FLAVANONE DERIVATIVE; HERBACEOUS AGENT; KRUPPEL LIKE FACTOR; ZINC FINGER PROTEIN, X-LINKED;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL VIABILITY; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; GALLBLADDER CANCER CELL LINE; HUMAN; HUMAN CELL; MALE; METASTASIS INHIBITION; MIGRATION INHIBITION; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; S PHASE CELL CYCLE CHECKPOINT; STRUCTURE ANALYSIS; ANIMAL; CARCINOMA; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; GALLBLADDER NEOPLASMS; GENETICS; NEOPLASM METASTASIS; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; DRUGS, CHINESE HERBAL; FLAVANONES; GALLBLADDER NEOPLASMS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE, NUDE; NEOPLASM METASTASIS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84921997216     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114851     Document Type: Article

References (35)

1. Miller G, JarnaginWR (2008) Gallbladder carcinoma. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 34: 306-312. doi: 10.1016/j.ejso.2007.07.206 PMID: 17964753
2. Li M, Zhang S, Wang Z, Zhang B, Wu X, et al. (2013) Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 34: 3995-4000. doi: 10.1007/s13277-013-0988-4 PMID: 23857283
3. Quan Z, Gu J, Dong P, Lu J, Wu X, et al. (2010) Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to cirsimaritin-induced apoptosis in human gallbladder carcinoma GBC-SD cells. Cancer letters 295: 252-259. doi: 10.1016/j.canlet.2010.03.008 PMID: 20359814
4. Li M, Shen J, Wu X, Zhang B, Zhang R, et al. (2013) Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion. Medical oncology 30: 587. doi: 10.1007/s12032-013-0587-7 PMID: 23609195
5. Liu TY, Tan ZJ, Jiang L, Gu JF, Wu XS, et al. (2013) Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells. Cancer cell international 13: 64. doi: 10.1186/1475-2867-13-64 PMID: 23802572
6. Wang JW, Peng SY, Li JT, Wang Y, Zhang ZP, et al. (2009) Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1. Cancer letters 281: 71-81. doi: 10.1016/j.canlet.2009.02.020 PMID: 19299076
7. Wang JD, Shi WB, Shen J, Zhuang PY, Quan ZW, et al. (2011) Evaluation of two modified ECF regimens in the treatment of advanced gallbladder cancer. Medical oncology 28 Suppl 1: S295-300. doi: 10.1007/s12032-010-9758-y PMID: 21136212
8. Dong P, He XW, Gu J, Wu WG, Li ML, et al. (2011) Vimentin significantly promoted gallbladder carcinoma metastasis. Chinese medical journal 124: 4236-4244. PMID: 22340393
9. Tan Z, Li M, Wu W, Zhang L, Ding Q, et al. (2012) NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells. Molecular and cellular biochemistry 369: 27-33. doi: 10.1007/s11010-012-1365-0 PMID: 22733362
10. Zhang Z, Wang X, Wu W, Wang J, Wang Y, et al. (2012) Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD). Phytotherapy research: PTR 26: 932-937. doi: 10.1002/ ptr.3657 PMID: 22162124
11. Shimada K, Nara S, Esaki M, Sakamoto Y, Kosuge T, et al. (2011) Extended right hemihepatectomy for gallbladder carcinoma involving the hepatic hilum. The British journal of surgery 98: 117-123. doi: 10.1002/bjs.7262 PMID: 21136566
12. Kimura Y, Kubo M, Tani T, Arichi S, Ohminami H, et al. (1981) Studies on Scutellariae radix. III. Effects on lipid metabolism in serum, liver and fat cells of rats. Chemical & pharmaceutical bulletin 29: 2308-2312. doi: 10.1248/cpb.29.2308 PMID: 7318038
13. Lin CC, Shieh DE (1996) The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. The American journal of Chinese medicine 24: 31-36. doi: 10.1142/S0192415X96000050 PMID: 8739179
14. Li-Weber M (2009) New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer treatment reviews 35: 57-68. doi: 10.1016/j.ctrv.2008.09.005 PMID: 19004559
15. Cheng YH, Li LA, Lin P, Cheng LC, Hung CH, et al. (2012) Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation. Toxicology and applied pharmacology 263: 360-367. doi: 10.1016/j.taap.2012.07.010 PMID: 22820424
16. Ma GZ, Liu CH, Wei B, Qiao J, Lu T, et al. (2013) Baicalein inhibits DMBA/TPA-induced skin tumorigenesis in mice by modulating proliferation, apoptosis, and inflammation. Inflammation 36: 457-467. doi: 10.1007/s10753-012-9566-y PMID: 23108957
17. Naveenkumar C, Raghunandhakumar S, Asokkumar S, Devaki T (2013) Baicalein abrogates reactive oxygen species (ROS)-mediated mitochondrial dysfunction during experimental pulmonary carcinogenesis in vivo. Basic & clinical pharmacology & toxicology 112: 270-281. doi: 10.1111/bcpt. 12025 PMID: 23061789
18. Chen J, Li Z, Chen AY, Ye X, Luo H, et al. (2013) Inhibitory effect of baicalin and baicalein on ovarian cancer cells. International journal of molecular sciences 14: 6012-6025. doi: 10.3390/ijms14036012 PMID: 23502466
19. Galan-Caridad JM, Harel S, Arenzana TL, Hou ZE, Doetsch FK, et al. (2007) Zfx controls the selfrenewal of embryonic and hematopoietic stem cells. Cell 129: 345-357. doi: 10.1016/j.cell.2007.03. 014 PMID: 17448993
20. Harel S, Tu EY, Weisberg S, Esquilin M, Chambers SM, et al. (2012) ZFX controls the self-renewal of human embryonic stem cells. PloS one 7: e42302. doi: 10.1371/journal.pone.0042302 PMID: 22879936
21. Yu S, Cui K, Jothi R, Zhao DM, Jing X, et al. (2011) GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells. Blood 117: 2166-2178. doi: 10.1182/blood-2010-09-306563 PMID: 21139080
22. Hu G, Kim J, Xu Q, Leng Y, Orkin SH, et al. (2009) A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes & development 23: 837-848. doi: 10.1101/ gad.1769609 PMID: 19339689
23. Cellot S, Sauvageau G (2007) Zfx: at the crossroads of survival and self-renewal. Cell 129: 239-241. doi: 10.1016/j.cell.2007.04.002 PMID: 17448983
24. Abdollahi A, Bao R, Hamilton TC (1999) LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein. Oncogene 18: 6477-6487. doi: 10.1038/sj.onc.1203067 PMID: 10597250
25. Buttar NS, Fernandez-Zapico ME, Urrutia R (2006) Key role of Kruppel-like factor proteins in pancreatic cancer and other gastrointestinal neoplasias. Current opinion in gastroenterology 22: 505-511. doi: 10.1097/01.mog.0000239864.73962.db PMID: 16891881
26. Zha W, Cao L, Shen Y, Huang M (2013) Roles of Mir-144-ZFX pathway in growth regulation of non-small-cell lung cancer. PloS one 8: e74175. doi: 10.1371/journal.pone.0074175 PMID: 24066116
27. Li K, Zhu ZC, Liu YJ, Liu JW, Wang HT, et al. (2013) ZFX knockdown inhibits growth and migration of non-small cell lung carcinoma cell line H1299. International journal of clinical and experimental pathology 6: 2460-2467. PMID: 24228108
28. Wu S, Lao XY, Sun TT, Ren LL, Kong X, et al. (2013) Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo via downregulating the ERK-MAPK pathway. Cancer letters 337: 293-300. doi: 10.1016/j.canlet.2013.04.003 PMID: 23587796
29. Akiyoshi S, Fukagawa T, Ueo H, Ishibashi M, Takahashi Y, et al. (2012) Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases. British journal of cancer 107: 1345-1353. doi: 10.1038/bjc.2012.326 PMID: 22955854
30. Tan Z, Zhang S, Li M, Wu X, Weng H, et al. (2013) Regulation of cell proliferation and migration in gallbladder cancer by zinc finger X-chromosomal protein. Gene 528: 261-266. doi: 10.1016/j.gene. 2013.06.064 PMID: 23860324
31. Huang WS, Kuo YH, Chin CC, Wang JY, Yu HR, et al. (2012) Proteomic analysis of the effects of baicalein on colorectal cancer cells. Proteomics 12: 810-819. doi: 10.1002/pmic.201100270 PMID: 22539432
32. Orrenius S (2004) Mitochondrial regulation of apoptotic cell death. Toxicology letters 149: 19-23. doi: 10.1016/j.toxlet.2003.12.017 PMID: 15093244
33. Chambers AF, Matrisian LM (1997) Changing views of the role of matrix metalloproteinases in metastasis. Journal of the National Cancer Institute 89: 1260-1270. doi: 10.1093/jnci/89.17.1260 PMID: 9293916
34. Shima I, Sasaguri Y, Kusukawa J, Yamana H, Fujita H, et al. (1992) Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 70: 2747-2753. doi: 10.1002/1097-0142(19921215)70:12<2747:: AID-CNCR2820701204>3.0.CO;2-5 PMID: 1451050
35. Ohashi K, Nemoto T, Nakamura K, Nemori R (2000) Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer 88: 2201-2209. doi: 10.1002/(SICI)1097-0142(20000515)88:10<2201::AID-CNCR2>3.0. CO;2-N PMID: 10820340